市場調査レポート
商品コード
1097833

心臓血管イメージング機器のパイプラインレポート:開発段階、セグメント、地域・国、規制パス、主要企業-2022年最新版

Cardiovascular Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

出版日: | 発行: GlobalData | ページ情報: 英文 73 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.33円
心臓血管イメージング機器のパイプラインレポート:開発段階、セグメント、地域・国、規制パス、主要企業-2022年最新版
出版日: 2022年06月07日
発行: GlobalData
ページ情報: 英文 73 Pages
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の心臓血管イメージング機器市場について調査分析し、開発中の心臓血管イメージング機器、主要パイプライン製品の詳細、心臓血管イメージング機器の開発に携わる主要企業のレビューとそのすべてのパイプラインプロジェクトのリスト、開発初期から承認/発行済み段階までさまざまな開発段階に基づくパイプライン製品、パイプライン製品に特化した進行中の主要な臨床試験データ、セグメント/業界における最近の開発状況等に関する情報を提供しています。

目次

第1章 目次

  • テーブルのリスト
  • 図のリスト

第2章 イントロダクション

  • 心臓血管イメージング機器の概要

第3章 開発中の製品

  • 心臓血管イメージング機器-開発段階別のパイプライン製品
  • 心臓血管イメージング機器-地域別のパイプライン製品
  • 心臓血管イメージング機器-規制パス別のパイプライン製品
  • 心臓血管イメージング機器-承認予定日までのパイプライン製品

第4章 心臓血管イメージング機器-企業が開発中のパイプライン製品

  • 心臓血管イメージング機器企業-開発段階別のパイプライン製品
  • 心臓血管イメージング機器-開発段階別のパイプライン製品

第5章 心臓血管イメージング機器企業と製品概要

  • Aetna Inc 企業概要
  • Beth Israel Deaconess Medical Center 企業概要
  • CardioPaint 企業概要
  • Centerline Biomedical Inc 企業概要
  • Cleveland Clinic Hospital 企業概要
  • Columbia University 企業概要
  • CorVista Health Inc 企業概要
  • Echopoint Medical Ltd 企業概要
  • Eindhoven University of Technology 企業概要
  • ElectroSonix LLC 企業概要
  • FMI Medical Systems Inc 企業概要
  • Illumasonix LLC (休止中) 企業概要
  • Johns Hopkins University 企業概要
  • King's College London 企業概要
  • Koninklijke Philips NV 企業概要
  • Massachusetts Institute of Technology 企業概要
  • Nano4Imaging GmbH 企業概要
  • Panoramic Hengsheng (Beijing) Science and
  • Technology Co Ltd 企業概要
  • Perinatronics Medical systems Inc 企業概要
  • Philips Ultrasound, Inc. 企業概要
  • Purdue University 企業概要
  • Tribogenics, Inc. 企業概要
  • University Health Network 企業概要
  • University of Colorado 企業概要
  • University of Glasgow 企業概要
  • University of Pittsburgh 企業概要
  • Vida Medical Devices Inc 企業概要
  • Vigilant Medical Inc 企業概要

第6章 心臓血管イメージング機器-最近の開発

第7章 付録

  • 調査手法
  • GlobalDataについて
  • お問い合わせ
  • 免責事項
図表

List of Tables

List of Tables

  • Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development
  • Cardiovascular Imaging Equipment - Pipeline Products by Territory
  • Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path
  • Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date
  • Cardiovascular Imaging Equipment Companies - Pipeline Products by Stage of Development
  • Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development
  • Cardiovascular Imaging Equipment - Pipeline Products by Territory
  • Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path
  • Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date
目次
Product Code: GDME1370EPD

GlobalData's Medical Devices sector report, "Cardiovascular Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Cardiovascular Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiovascular Imaging Equipment are the imaging devices that capture the images of heart to diagnose the condition of heart.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Imaging Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Imaging Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Imaging Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Cardiovascular Imaging Equipment Overview

3 Products under Development

  • 3.1 Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development
  • 3.2 Cardiovascular Imaging Equipment - Pipeline Products by Territory
  • 3.3 Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path
  • 3.4 Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date

4 Cardiovascular Imaging Equipment - Pipeline Products under Development by Companies

  • 4.1 Cardiovascular Imaging Equipment Companies - Pipeline Products by Stage of Development
  • 4.2 Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development

5 Cardiovascular Imaging Equipment Companies and Product Overview

  • 5.1 Aetna Inc Company Overview
  • 5.2 Beth Israel Deaconess Medical Center Company Overview
  • 5.3 CardioPaint Company Overview
  • 5.4 Centerline Biomedical Inc Company Overview
  • 5.5 Cleveland Clinic Hospital Company Overview
  • 5.6 Columbia University Company Overview
  • 5.7 CorVista Health Inc Company Overview
  • 5.8 Echopoint Medical Ltd Company Overview
  • 5.9 Eindhoven University of Technology Company Overview
  • 5.10 ElectroSonix LLC Company Overview
  • 5.11 FMI Medical Systems Inc Company Overview
  • 5.12 Illumasonix LLC (Inactive) Company Overview
  • 5.13 Johns Hopkins University Company Overview
  • 5.14 King's College London Company Overview
  • 5.15 Koninklijke Philips NV Company Overview
  • 5.16 Massachusetts Institute of Technology Company Overview
  • 5.17 Nano4Imaging GmbH Company Overview
  • 5.18 Panoramic Hengsheng (Beijing) Science and Technology Co Ltd Company Overview
  • 5.19 Perinatronics Medical systems Inc Company Overview
  • 5.20 Philips Ultrasound, Inc. Company Overview
  • 5.21 Purdue University Company Overview
  • 5.22 Tribogenics, Inc. Company Overview
  • 5.23 University Health Network Company Overview
  • 5.24 University of Colorado Company Overview
  • 5.25 University of Glasgow Company Overview
  • 5.26 University of Pittsburgh Company Overview
  • 5.27 Vida Medical Devices Inc Company Overview
  • 5.28 Vigilant Medical Inc Company Overview

6 Cardiovascular Imaging Equipment- Recent Developments

  • 6.1 May 10, 2022: Stereotaxis Reports 2022 First Quarter Financial Results
  • 6.2 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
  • 6.3 Apr 28, 2022: LeMaitre Q1 2022 Financial Results
  • 6.4 Apr 15, 2022: LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022
  • 6.5 Mar 30, 2022: Broncus Medical Announces Annual Results for 2021: Operating revenue for 2021 increased 234.2% year-on-year, while product development and commercialization are steadily advancing.
  • 6.6 Mar 09, 2022: Stereotaxis Announces Grand Opening of New Global Headquarters in St. Louis
  • 6.7 Mar 01, 2022: HeartFlow Announces CEO Transition
  • 6.8 Feb 24, 2022: LeMaitre Q4 2021 Financial Results
  • 6.9 Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022
  • 6.10 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
  • 6.11 Jan 03, 2022: MediBalloon expands operations and establishes mass production capabilities in Taiwan's Medeologix
  • 6.12 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
  • 6.13 Oct 28, 2021: Stereotaxis to Report Third Quarter 2021 Financial Results on November 11, 2021
  • 6.14 Oct 28, 2021: LeMaitre Q3 2021 Financial Results
  • 6.15 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
  • 6.16 Oct 19, 2021: Pivotal consensus statement for Medistim's transit time flow technology (TTFM) published in Circulation
  • 6.17 Oct 14, 2021: LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021
  • 6.18 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
  • 6.19 Aug 13, 2021: Medistim Announces Second quarter and first half financials 2021
  • 6.20 Jul 29, 2021: LeMaitre Q2 2021 Financial Results
  • 6.21 Jul 26, 2021: Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.
  • 6.22 Jul 20, 2021: Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021
  • 6.23 Jul 15, 2021: LeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021
  • 6.24 Jul 13, 2021: LeMaitre Provides Q2 2021 Update
  • 6.25 Jun 24, 2021: Peter Arduini named CEO of GE healthcare
  • 6.26 Jun 22, 2021: Angel Medical Systems Announces Brad Snow as Interim Chief Executive Officer
  • 6.27 Jun 03, 2021: GE Healthcare and the American College of Cardiology join forces to advance AI in cardiac care

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer